1. Home
  2. HUMA vs WENN Comparison

HUMA vs WENN Comparison

Compare HUMA & WENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • WENN
  • Stock Information
  • Founded
  • HUMA 2004
  • WENN 2025
  • Country
  • HUMA United States
  • WENN United States
  • Employees
  • HUMA N/A
  • WENN N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • WENN
  • Sector
  • HUMA Health Care
  • WENN
  • Exchange
  • HUMA Nasdaq
  • WENN Nasdaq
  • Market Cap
  • HUMA 324.0M
  • WENN 387.6M
  • IPO Year
  • HUMA N/A
  • WENN 2025
  • Fundamental
  • Price
  • HUMA $1.67
  • WENN $10.24
  • Analyst Decision
  • HUMA Strong Buy
  • WENN
  • Analyst Count
  • HUMA 7
  • WENN 0
  • Target Price
  • HUMA $10.00
  • WENN N/A
  • AVG Volume (30 Days)
  • HUMA 7.5M
  • WENN 28.7K
  • Earning Date
  • HUMA 11-07-2025
  • WENN 01-01-0001
  • Dividend Yield
  • HUMA N/A
  • WENN N/A
  • EPS Growth
  • HUMA N/A
  • WENN N/A
  • EPS
  • HUMA N/A
  • WENN N/A
  • Revenue
  • HUMA $818,000.00
  • WENN N/A
  • Revenue This Year
  • HUMA N/A
  • WENN N/A
  • Revenue Next Year
  • HUMA $1,468.13
  • WENN N/A
  • P/E Ratio
  • HUMA N/A
  • WENN N/A
  • Revenue Growth
  • HUMA N/A
  • WENN N/A
  • 52 Week Low
  • HUMA $1.15
  • WENN $9.67
  • 52 Week High
  • HUMA $6.77
  • WENN $10.40
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 47.73
  • WENN N/A
  • Support Level
  • HUMA $1.65
  • WENN N/A
  • Resistance Level
  • HUMA $1.78
  • WENN N/A
  • Average True Range (ATR)
  • HUMA 0.10
  • WENN 0.00
  • MACD
  • HUMA -0.01
  • WENN 0.00
  • Stochastic Oscillator
  • HUMA 23.73
  • WENN 0.00

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About WENN Wen Acquisition Corp Class A Ordinary Shares

Wen Acquisition Corp is a blank check company.

Share on Social Networks: